Gamco Investors INC. ET AL Sells 3,254 Shares of Stryker Corporation $SYK

Gamco Investors INC. ET AL lowered its holdings in Stryker Corporation (NYSE:SYK) by 14.7% in the fourth quarter, HoldingsChannel.com reports. The firm owned 18,820 shares of the medical technology company’s stock after selling 3,254 shares during the quarter. Gamco Investors INC. ET AL’s holdings in Stryker were worth $6,615,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently bought and sold shares of the company. United Financial Planning Group LLC bought a new position in Stryker during the 3rd quarter worth $27,000. Strive Asset Management LLC bought a new position in Stryker during the 3rd quarter worth $30,000. CGC Financial Services LLC bought a new position in Stryker during the 4th quarter worth $29,000. ANTIPODES PARTNERS Ltd bought a new position in Stryker during the 3rd quarter worth $34,000. Finally, Copia Wealth Management increased its stake in Stryker by 181.6% during the 3rd quarter. Copia Wealth Management now owns 107 shares of the medical technology company’s stock worth $40,000 after acquiring an additional 69 shares during the period. Institutional investors own 77.09% of the company’s stock.

Analyst Ratings Changes

SYK has been the topic of a number of recent research reports. Truist Financial restated a “hold” rating and set a $330.00 price objective (down from $380.00) on shares of Stryker in a research note on Monday, May 4th. JPMorgan Chase & Co. cut their price objective on shares of Stryker from $445.00 to $400.00 and set an “overweight” rating for the company in a research report on Friday, May 1st. Wall Street Zen cut shares of Stryker from a “buy” rating to a “hold” rating in a research report on Saturday. Sanford C. Bernstein set a $410.00 price objective on shares of Stryker in a research report on Friday, May 1st. Finally, Wells Fargo & Company cut their price objective on shares of Stryker from $456.00 to $418.00 and set an “overweight” rating for the company in a research report on Friday, May 1st. Sixteen investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $395.48.

Stryker Price Performance

Shares of SYK stock opened at $317.81 on Wednesday. The company has a quick ratio of 1.25, a current ratio of 2.11 and a debt-to-equity ratio of 0.62. Stryker Corporation has a twelve month low of $281.00 and a twelve month high of $404.87. The company has a market cap of $121.84 billion, a P/E ratio of 36.78, a P/E/G ratio of 1.97 and a beta of 0.80. The business has a fifty day simple moving average of $327.61 and a 200 day simple moving average of $350.70.

Stryker (NYSE:SYK) last announced its quarterly earnings data on Thursday, April 30th. The medical technology company reported $2.60 earnings per share for the quarter, missing the consensus estimate of $2.98 by ($0.38). Stryker had a return on equity of 23.42% and a net margin of 13.20%.The business had revenue of $6.02 billion for the quarter, compared to the consensus estimate of $6.34 billion. During the same quarter in the prior year, the company earned $2.84 earnings per share. Stryker’s quarterly revenue was up 2.6% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. On average, sell-side analysts forecast that Stryker Corporation will post 14.98 EPS for the current fiscal year.

Stryker Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Tuesday, June 30th will be issued a dividend of $0.88 per share. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $3.52 annualized dividend and a dividend yield of 1.1%. Stryker’s payout ratio is 40.74%.

Insider Activity

In related news, VP M Kathryn Fink sold 3,500 shares of Stryker stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $283.45, for a total transaction of $992,075.00. Following the sale, the vice president directly owned 177 shares of the company’s stock, valued at approximately $50,170.65. The trade was a 95.19% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 4.60% of the company’s stock.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.